PPW
SGMO icon

Pasadena Private Wealth’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Pasadena Private Wealth’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,093
Closed -$5.46K – 321
2026
Q1 		$5.46K Buy
+22,093
New +$8.79K ﹤0.01% 263

Other funds holding SGMO

Nomura Asset Management International
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
AIM
Axiom Investment Management New York $150M AUM
Flow Traders U.S.
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
HIG
Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Pasadena Private Wealth's SGMO Position: Q2 2026 in Review

Pasadena Private Wealth sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 22,093 shares — an estimated $5.46K sold.

Pasadena Private Wealth first reported a position in SGMO in Q1 2026 and held it in 1 quarter. The position peaked at $5.46K in Q1 2026. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

  • Pasadena Private Wealth reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
  • Pasadena Private Wealth sold 22,093 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $5.46K.
  • Pasadena Private Wealth first reported a position in SANGAMO THERAPEUTICS INC in Q1 2026 and held it in 1 quarter.
  • Pasadena Private Wealth's SANGAMO THERAPEUTICS INC position peaked at $5.46K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Pasadena Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.